A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2007
11/21/2007	CN100349632C Microprojection array having beneficial agent contg coating
11/21/2007	CN100349631C Apparatus for and methods of administering volatile substances into inhalation flow path
11/21/2007	CN100349613C Botulinum toxin oral formulation and use thereof for treating peptic ulcers and gastroesophageal reflux disease
11/21/2007	CN100349612C Sustained releasing microspheric preparation of glucokinase mutant and its making method
11/21/2007	CN100349611C Redfish calcitonin inhalation powder-atomizing agent and preparing method
11/21/2007	CN100349610C Oral adhering piece for treating oral exulceratio, and its prepn. method
11/21/2007	CN100349607C Extraction and purification of Chinese medicine for treating ulcer colonitis and clinical research
11/21/2007	CN100349606C Drug tincture for treating flat wart, and preparation method
11/21/2007	CN100349604C Medicine for treating skin scald and burn and preparation method thereof
11/21/2007	CN100349600C Chinese medicinal compositino for fortifying immunity, improving anoxia tolerance and its preparation method
11/21/2007	CN100349598C Medicine for treating high lipemia and its production method
11/21/2007	CN100349595C Medicinal composition for catharsis
11/21/2007	CN100349593C Bone-setting pain-stopping plaster
11/21/2007	CN100349587C Medicine for treating acute and chronic pancreatitis
11/21/2007	CN100349585C Dampness dispersing, cancer resisting medicine, its preparation method and its application in the process for preparing anticancer medicine
11/21/2007	CN100349584C Dropping pill for treating throat disease and preparing method thereof
11/21/2007	CN100349583C Chinese traditional medicine for treating chronic nephritis
11/21/2007	CN100349582C Oil seed bruceae lyophilized powder for injection and its preparing method
11/21/2007	CN100349581C Traditional Chinese medicine for treating cancer and tumor and all kinds of inflammatory disease
11/21/2007	CN100349580C Mould catching agent and medicinal/health caring use
11/21/2007	CN100349573C Formulation for lipophilic agents
11/21/2007	CN100349571C Transdermal therapeutic system containing testosterone and method for the production thereof
11/21/2007	CN100349570C 10-hydoxy camptothecin self micro emulsifieation composition
11/21/2007	CN100349568C Intravenous administered injection of ginkgolide B, its preparation method and application
11/21/2007	CN100349567C (-)-epigallocatechin gallate-magnesium complex solid dispersion and its prepn and application
11/21/2007	CN100349565C Curcumenol solid lipid nano-particle and its preparation method
11/21/2007	CN100349564C Low alcohol type concentrated soloution for nourishing yin to clear away the lung-heat, preparation method and application
11/21/2007	CN100349562C Ophthalmic drug delivery device
11/20/2007	US7297794 Phenoxy amine compounds and compositions for delivering active agents
11/20/2007	US7297759 Peptides for increasing transfection efficiency
11/20/2007	US7297712 Coupling an aliphatic bromide with an aliphatic alkylamine, protecting both terminal primary alcohol groups of aliphatic alcohol, reacting both intermediates, quaternizing the product, passing quaternized product through a chroamtograph
11/20/2007	US7297655 Catalyst and its use in desulphurisation
11/20/2007	US7297404 Microencapsulated particles and process for manufacturing same
11/20/2007	US7297353 For oral administration, injection and topical application; can eliminate the aseptic inflammations, edema, adhesion caused by aseptic inflammations, and stubborn pain, complex body disorders caused by aseptic inflammation, edema and adhesion
11/20/2007	US7297348 Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from
11/20/2007	US7297347 Polyanhydrides
11/20/2007	US7297346 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain attention deficit hyperactivity disorder and fatigue
11/20/2007	US7297345 Using compression, thermal cycle molding, and thermal setting molding modules in continuous process
11/20/2007	US7297344 Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
11/20/2007	US7297328 Surfactant-free cosmetic, dermatological and pharmaceutical agents
11/20/2007	US7297314 fluidizing gas introduced from bottom portion of processing container causes powder particles to form a fluidized bed which circulate to ascend through a space between an inner wall of the processing container and the draft tube and descend through inner portion of draft tube; dispersed by disintegrator
11/20/2007	CA2499187C A delivery system and a manufacturing process of a delivery system
11/20/2007	CA2441549C Ipratropium formulation for pulmonary inhalation
11/20/2007	CA2417843C Administration of an injectable antibiotic in the ear of an animal
11/20/2007	CA2405205C Method for preparing microspheres
11/20/2007	CA2378265C Solid preparations containing chitosan powder and process for producing the same
11/20/2007	CA2361620C Bone-derived implant for load-supporting applications
11/20/2007	CA2341410C Hydrogel compositions for the controlled release administration of growth factors
11/20/2007	CA2318138C Vitamin d solution holder and containers for transfusions
11/20/2007	CA2316841C Crystallographically stable amorphous cephalosporin compositions and process for producing the same
11/20/2007	CA2260926C Illudin analogs useful as antitumor agents
11/20/2007	CA2254144C Pharmaceutical compositions based on diclofenac
11/20/2007	CA2234615C Sustained release particles
11/20/2007	CA2216372C Oral 2-methyl-thieno-benzodiazepine formulation
11/20/2007	CA2214436C Corticosteroid-containing pharmaceutical composition
11/20/2007	CA2211389C Novel pharmaceutical combination
11/20/2007	CA2200746C Injection-molded dosage form
11/20/2007	CA2186126C Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
11/15/2007	WO2007131128A2 Systems and methods for producing multilayered particles, fibers and sprays and methods for administering the same
11/15/2007	WO2007130960A2 Stable ophthalmic oil-in-water emulsions with omega-3 fatty acids for alleviating dry eye
11/15/2007	WO2007130945A1 A sustained-release intraocular implant comprising a vasoactive agent
11/15/2007	WO2007130930A2 Implant depots to deliver growth factors to treat osteoporotic bone
11/15/2007	WO2007130652A2 Lumen-traveling delivery device
11/15/2007	WO2007130639A2 Lumen-traveling device
11/15/2007	WO2007130634A2 Lumen-traveling biological interface device and method of use
11/15/2007	WO2007130586A2 Controllable release nasal system
11/15/2007	WO2007130566A2 Lumen-traveling biological interface device
11/15/2007	WO2007130564A2 Bioelectromagnetic interface system
11/15/2007	WO2007130478A2 Heated roller compaction process for making pharmaceutical compositions
11/15/2007	WO2007130373A2 Novel triptan formulations and methods for making them
11/15/2007	WO2007130134A2 Controlled release microparticles
11/15/2007	WO2007129961A1 Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
11/15/2007	WO2007129926A2 Production and recovery of polymeric micro- and nanoparticles containing bioactive macromolecules
11/15/2007	WO2007129837A1 Composition for transdermal absorption and formulation comprising a polymeric matrix formed therefrom
11/15/2007	WO2007129712A1 Transdermally absorbable donepezil preparation
11/15/2007	WO2007129706A1 Edible film package having product for oral intake enclosed therein
11/15/2007	WO2007129522A1 Preparation produced by dry process
11/15/2007	WO2007129427A1 Tansdermally absorbable preparation comprising anti-dementia agent
11/15/2007	WO2007129330A1 Pharmaceutical and cosmetic use of silica
11/15/2007	WO2007129329A2 Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
11/15/2007	WO2007129240A1 Device and method for the controlled release of a predefined quantity of a substance
11/15/2007	WO2007129178A2 Pharmaceutical compositions comprising non-steroidal antiinflammatory drug, antipyretic- analgesic drug and proton pump inhibitor
11/15/2007	WO2007129162A2 Pharmaceutical preparations for transdermal use
11/15/2007	WO2007128926A1 Paste for use as a bandage on mucous membranes of the oral cavity or on the skin
11/15/2007	WO2007128923A2 Method for the preparation of a biocompatible gel with controlled release of one or more active ingredients with low solubility in water, gels thus obtained and their use
11/15/2007	WO2007128724A1 Dpp iv inhibitor formulations
11/15/2007	WO2007128495A2 Solid pharmaceutical composition of gabapentin
11/15/2007	WO2007128478A2 Pharmaceutical composition
11/15/2007	WO2007128350A1 Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions
11/15/2007	WO2007128349A1 Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions
11/15/2007	WO2007128107A1 Modified release tablets comprising tramadol
11/15/2007	WO2007128066A1 Drug release from nanoparticle-coated capsules
11/15/2007	WO2007111925A3 Zotarolimus-containing drug delivery systems for implantation into a body lumen of a subject
11/15/2007	WO2007107679A3 Association of oleaginous substance with a mixture of at least two cyclodextrins
11/15/2007	WO2007106723A3 Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
11/15/2007	WO2007106549A3 Method for treating brain cancer
11/15/2007	WO2007103293A3 Ethanol-resistant sustained release formulations
11/15/2007	WO2007102915A3 Encapsulated phospholipid-stabilized oxidizable material
11/15/2007	WO2007100984A3 Beads containing pyridin-sulfinyl benzoimidazole sulfonyl phenoxy acetate derivatives
11/15/2007	WO2007097936A3 Protein hydrolysate excipients

1 ... 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 ... 2991